JAQINUS Trademark

Trademark Overview

On Friday, January 16, 2009, a trademark application was filed for JAQINUS with the United States Patent and Trademark Office. The USPTO has given the JAQINUS trademark a serial number of 77650949. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2018. This trademark is owned by Pfizer Inc.. The JAQINUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immunological and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations, namely, dermatological preparations
jaqinus

General Information

Serial Number77650949
Word MarkJAQINUS
Filing DateFriday, January 16, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 28, 2018
Registration Number4102708
Registration DateTuesday, February 21, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of immunological and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations, namely, dermatological preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 28, 2018
Primary Code005
First Use Anywhere DateThursday, October 20, 2011
First Use In Commerce DateThursday, October 20, 2011

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, September 28, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, February 21, 2012REGISTERED-PRINCIPAL REGISTER
Saturday, January 14, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Friday, January 13, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, January 13, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 13, 2012STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 13, 2011USE AMENDMENT FILED
Tuesday, December 13, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, July 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Saturday, July 16, 2011EXTENSION 4 GRANTED
Friday, July 15, 2011EXTENSION 4 FILED
Friday, July 15, 2011TEAS EXTENSION RECEIVED
Wednesday, January 26, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, January 25, 2011EXTENSION 3 GRANTED
Monday, January 24, 2011EXTENSION 3 FILED
Monday, January 24, 2011TEAS EXTENSION RECEIVED
Wednesday, August 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, August 24, 2010EXTENSION 2 GRANTED
Tuesday, July 27, 2010EXTENSION 2 FILED
Tuesday, August 24, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 27, 2010TEAS EXTENSION RECEIVED
Thursday, January 28, 2010EXTENSION 1 GRANTED
Thursday, January 28, 2010EXTENSION 1 FILED
Thursday, January 28, 2010TEAS EXTENSION RECEIVED
Wednesday, December 23, 2009ASSIGNED TO EXAMINER
Tuesday, July 28, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 5, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2009NOTICE OF PUBLICATION
Wednesday, April 1, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 1, 2009ASSIGNED TO LIE
Wednesday, April 1, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 25, 2009ASSIGNED TO EXAMINER
Wednesday, January 21, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

jaqinus preparations pharmaceutical treatment namely pain dermatological inflammatory immunological diseases disorders